Indole Alkaloids and Phenazine Antibiotics: New Platforms for Drug Discovery
吲哚生物碱和吩嗪抗生素:药物发现的新平台
基本信息
- 批准号:10217189
- 负责人:
- 金额:$ 34.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AntibioticsAreaAwardBacteriaBacterial InfectionsBiologicalBiological PhenomenaBiological ProcessBiologyCancer BiologyCell SurvivalCellsCessation of lifeChemicalsChemistryComplexCritical PathwaysDiseaseEngineeringG-Protein-Coupled ReceptorsGoalsHealthHumanIn VitroIndole AlkaloidsInvestigationLeadLibrariesMicrobial BiofilmsNatural ProductsParentsPhenazinesPlasmodium falciparumProdrugsReactionSeriesSurfaceSystemTherapeutic AgentsUnited StatesYohimbinebacterial communitybasechemical synthesisdrug discoveryexperimental studyhuman diseaseinnovationinsightmethicillin resistant Staphylococcus aureusoxidationpersistent bacterial infectionpublic health relevancescaffoldsmall moleculetranscriptome sequencing
项目摘要
Indole Alkaloids and Phenazine Antibiotics: New Platforms For Drug Discovery
Abstract:
New small molecule probes and therapeutic agents are critical for the study and treatment of human
disease. Our group is developing multiple chemical synthesis strategies to probe diverse biological
phenomena related to human disease, including: bacterial biofilm viability, GPCR function, cancer
biology and Plasmodium falciparum biology. We have developed a tryptoline-based ring distortion
strategy using commercially available indole alkaloids (yohimbine and vincamine) as starting points for
ring distortion, or the dramatic altering/reorganization of complex ring systems using chemoselective
reactions. This approach has enabled the rapid synthesis of highly complex and diverse scaffolds for
biological investigations and we have identified hit compounds in multiple disease-relevant areas
pertinent to human health. Our hit compounds have gained new biological functions as their biological
activities are unrelated to other scaffolds or their parent natural product, in essence, re-engineering of
indole alkaloid’s chemical scaffolds and biological functions have been demonstrated. During this award,
we will enhance the chemical diversity of our indole alkaloid ring distortion library by using C-H oxidation
chemistry to install new synthetic handles for ring distortion and diastereoselective oxidative
rearrangements to give new spirooxindole scaffolds with the ultimate goal of exploring disease-relevant
chemical space with our probe molecules. In addition, our group has identified a series of halogenated
phenazines (HP) that demonstrate potent biofilm-eradicating activities. These findings are significant as
bacterial biofilms, or surface-attached bacterial communities, house persistent, non-replicating bacteria
(persister cells) that demonstrate tolerance to all classes of antibiotics. Biofilms pose a significant threat
to human health as 17 million new biofilm-associated bacterial infections occur annually that result in
550,000 deaths in the United States. We aim to use the HP small molecules we have developed as
probe molecules in RNA-seq experiments with MRSA biofilms alongside other biofilm-killing agents to
investigate biofilm viability with the goal of identifying new targets and cellular pathways critical to
bacterial biofilms. In addition, we aim to develop a diverse array of HP prodrugs through chemical
synthesis and in vitro biological studies. Providing new insights into the basic biology critical to biofilm
cell viability and developing new biofilm-eradicating prodrugs could lead to ground-breaking cures for
persistent bacterial infections.
Huigens (PI) Project Summary/Abstract
吲哚生物碱和苯嗪抗生素:药物发现的新平台
抽象的:
新的小分子问题和治疗剂对于人类的研究和治疗至关重要
疾病。我们的小组正在开发多种化学合成策略来探测潜水员生物学
与人类疾病有关的现象,包括:细菌生物膜生存能力,GPCR功能,癌症
生物学和恶性疟原虫生物学。我们已经开发了基于斜利的环形失真
使用市售吲哚生物碱(Yohimbine和Vincamine)作为起点的策略
环形失真,或使用化学选择性的复杂环系统的急剧改变/重组
反应。这种方法使高度复杂和潜水的脚手架的快速合成
生物学研究,我们已经确定了与多种疾病相关的地区的HIT化合物
与人类健康有关。我们的热门化合物已获得新的生物学功能作为其生物学
活动与其他脚手架或其父母自然产品无关,本质上是重新设计的
已经证明了吲哚生物碱的化学支架和生物学功能。在此奖励期间,
我们将使用C-H氧化来增强吲哚生物碱环失真文库的化学多样性
化学以安装新的合成手柄,用于环形失真和映射氧化物
重排以提供新的Spiooxindole脚手架,以探索与疾病相关的最终目标
带有探针分子的化学空间。此外,我们的小组已经确定了一系列卤素
表现出潜在的生物膜化学活性的苯胺(HP)。这些发现很重要,因为
细菌生物膜或表面附着的细菌群落,房屋持续,无重复的细菌
(持久细胞)证明对所有类别的抗生素的耐受性。生物膜构成重大威胁
对于人类健康,每年发生1700万新生物膜相关的细菌感染,这导致
美国550,000人死亡。我们的目标是使用我们开发的HP小分子
用MRSA生物膜与其他生物膜杀菌剂一起进行RNA-Seq实验中的探针分子
研究生物膜生存能力,目的是确定新目标和细胞途径至关重要
细菌生物膜。此外,我们旨在通过化学制造一系列HP前药阵列
合成和体外生物学研究。提供对生物膜至关重要的基本生物学的新见解
细胞活力和开发新的生物膜化学前药可能导致开创性的治疗方法
持续的细菌感染。
Huigens(PI)项目摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert William Huigens其他文献
Robert William Huigens的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert William Huigens', 18)}}的其他基金
Optimization and mechanistic studies of halogenated phenazines and quinolines as anti-tuberculosis therapeutics
卤代吩嗪和喹啉类抗结核药物的优化及机理研究
- 批准号:
10377920 - 财政年份:2021
- 资助金额:
$ 34.77万 - 项目类别:
Optimization and mechanistic studies of halogenated phenazines and quinolines as anti-tuberculosis therapeutics
卤代吩嗪和喹啉类抗结核药物的优化及机理研究
- 批准号:
10193679 - 财政年份:2021
- 资助金额:
$ 34.77万 - 项目类别:
Indole Alkaloids and Phenazine Antibiotics: New Platforms for Drug Discovery
吲哚生物碱和吩嗪抗生素:药物发现的新平台
- 批准号:
9983101 - 财政年份:2018
- 资助金额:
$ 34.77万 - 项目类别:
Indole Alkaloids and Phenazine Antibiotics: New Platforms for Drug Discovery
吲哚生物碱和吩嗪抗生素:药物发现的新平台
- 批准号:
10451729 - 财政年份:2018
- 资助金额:
$ 34.77万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Derivation and Validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) Score
儿科社区获得性肺炎严重程度 (PedCAPS) 评分的推导和验证
- 批准号:
10587951 - 财政年份:2023
- 资助金额:
$ 34.77万 - 项目类别:
Clinical decision support algorithm to optimize management of respiratory tract infection in children attending primary health facilities in Kilimanjaro Region, Tanzania
用于优化坦桑尼亚乞力马扎罗地区初级卫生机构儿童呼吸道感染管理的临床决策支持算法
- 批准号:
10734148 - 财政年份:2023
- 资助金额:
$ 34.77万 - 项目类别:
Implicit racial bias in pediatric emergency medicine: A foundational investigation of physician behaviors
儿科急诊医学中的隐性种族偏见:对医生行为的基础调查
- 批准号:
10722681 - 财政年份:2023
- 资助金额:
$ 34.77万 - 项目类别:
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
- 批准号:
10588846 - 财政年份:2023
- 资助金额:
$ 34.77万 - 项目类别:
Changes in Enteric Microbiota and Inflammation with HIV PrEP
HIV PrEP 引起的肠道微生物群变化和炎症
- 批准号:
10700595 - 财政年份:2023
- 资助金额:
$ 34.77万 - 项目类别: